STOCK TITAN

Enfusion Inc Stock Price, News & Analysis

ENFN NYSE

Welcome to our dedicated page for Enfusion news (Ticker: ENFN), a resource for investors and traders seeking the latest updates and insights on Enfusion stock.

Enfusion, Inc. (ENFN) appears in financial news as a provider of software-as-a-service solutions for investment managers, hedge funds, and asset managers, and as the subject of a completed acquisition by Clearwater Analytics Holdings, Inc. News coverage highlights Enfusion’s role in the investment management technology landscape and its integration into Clearwater’s broader platform.

Readers of this ENFN news page can expect articles that discuss Enfusion’s corporate transactions, including the definitive merger agreement announced with Clearwater and the subsequent completion of that acquisition in a transaction valued at approximately $1.5 billion. News items also describe the strategic rationale for combining Enfusion’s front-office capabilities with Clearwater’s middle- and back-office solutions to create a unified, cloud-native front-to-back investment management platform.

Historical news about Enfusion includes financial results such as fourth quarter and full year 2024 performance, where the company reported revenues, margins, and key metrics like Annual Recurring Revenue and Net Dollar Retention Rate. Such releases provide insight into Enfusion’s business model as a SaaS platform serving investment managers with platform subscriptions and managed services.

Other news references Enfusion’s positioning in the hedge fund and asset management sectors and its global footprint, as well as its description as an investment management SaaS platform that unites front-, middle-, and back-office teams. Following the acquisition, additional coverage focuses on how Enfusion’s technology is being used within Clearwater’s platform to support institutional investors.

Investors and researchers can use this ENFN news feed as an archive of transaction announcements, earnings-related disclosures, and strategic updates involving Enfusion, both as an independent public company and as part of Clearwater Analytics.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.8%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.53%
Tags
AI
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.23%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.8%
Tags
management
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.86%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.18%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.84%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.34%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.1%
Tags
none

FAQ

What is the current stock price of Enfusion (ENFN)?

The current stock price of Enfusion (ENFN) is $10.76 as of April 22, 2025.

What is the market cap of Enfusion (ENFN)?

The market cap of Enfusion (ENFN) is approximately 1.0B.

ENFN Rankings

ENFN Stock Data

1.04B
88.71M
Software Publishers
Services-prepackaged Software
Link
US
CHICAGO

ENFN RSS Feed